Summary of Ingersoll Rand Conference Call Company Overview - **Company**: Ingersoll Rand - **CFO**: Vik Kini - **Context**: Discussion on the company's performance since the merger in 2020, focusing on growth, acquisitions, and market dynamics Key Points Business Performance and Growth - Ingersoll Rand has achieved solid organic growth momentum over the past 5-6 years, with an improved margin profile and strong free cash flow [2][3] - The company has completed **76 acquisitions** since the merger, contributing to its global portfolio [3] - Current revenue is approaching **$8 billion** in a **$65 billion+** addressable market, indicating significant growth potential [3] Financial Metrics - Annual free cash flow generation is between **$1.2 billion and $1.3 billion**, with ongoing optimization efforts [10] - The company aims for organic growth expectations of **0%-2%** for the upcoming year, reflecting a cautious approach to market recovery [21] Market Dynamics - Ingersoll Rand is experiencing low single-digit organic orders momentum, with a focus on innovation and recurring revenue [16][21] - The company is not currently factoring in a broader industrial recovery in its guidance, preferring to observe market trends before adjusting expectations [21] Regional Performance - **China**: Represents about **10%-11%** of total revenue, with recent low single-digit organic order growth. The company has adapted by localizing acquired technologies [60][62] - **Asia (excluding China)**: Achieved **20%** organic order growth in Q4, indicating strong momentum in under-penetrated markets like Southeast Asia and India [76][88] - **Europe**: Stable performance with growth in Central Europe, driven by sustainability initiatives and project opportunities [99][101] - **Americas**: Currently a low single-digit grower, with potential for improvement due to life sciences momentum and reshoring trends [109] Life Sciences Segment - Life sciences is the largest business segment, accounting for nearly **20%** of the company, with mid-teens growth expected to continue [46][55] - The segment includes OEM components for medical labs and biopharma, showing healthy growth across all components [55] Margin Expansion - The company maintains a **29% EBITDA margin** despite macro headwinds, with expectations for margin expansion in 2026 [91][169] - Targeting triple-digit margin expansion for the Precision and Science Technologies (PST) segment, with a mid-30s adjusted EBITDA margin target for 2027 [169] Recurring Revenue Model - The recurring revenue initiative has grown from **$200 million** in 2023 to **$450 million** in 2025, with a target of **$1 billion** by 2027 [124][140] - The model is expanding beyond compressors to include other technologies, indicating strong global adoption [131] Use of AI and Technology - Ingersoll Rand is leveraging AI to enhance product connectivity and efficiency, focusing on both product technology and sales force efficiency [142][146] Challenges and Risks - The company faces challenges related to tariffs and commodity price fluctuations, which may impact margins [148][156] - There is a cautious approach to pricing strategies to offset tariffs without compromising margins [148] Conclusion - Ingersoll Rand is positioned for continued growth through strategic acquisitions, a focus on innovation, and expansion in under-penetrated markets. The company remains cautious in its guidance while optimistic about future opportunities in various segments and regions.

Financial Data and Key Metrics Changes - Year-to-date organic orders increased by 2%, with a book-to-bill ratio of 1.04 times [4] - Adjusted EBITDA for Q3 was $545 million, with an adjusted EBITDA margin of 27.9% [8] - Adjusted EPS for the quarter was $0.86, up 2% year-over-year [9] - Free cash flow for Q3 was $326 million, approximately flat year-over-year [9] - Total liquidity stood at $3.8 billion, with leverage increasing modestly to 1.8 times [10] Business Line Data and Key Metrics Changes - In the ITS segment, Q3 orders were up 7%, with a book-to-bill of 0.99 times [11] - PST segment orders increased by 11% year-over-year, with organic orders up 7% [13] - Adjusted EBITDA for PST was $128 million, up 8% year-over-year, with a margin of 30.8% [13] Market Data and Key Metrics Changes - Orders in the Americas, Europe, the Middle East, and India, Africa were up high single digits, while Asia-Pacific saw mid-single-digit growth [12] - The company noted a positive trend in organic orders across all regions except for the vacuum and blower business [22] Company Strategy and Development Direction - The company remains focused on disciplined M&A, having closed 14 transactions year-to-date, with nine additional transactions under letters of intent [5] - The acquisition of DayBerry Plastics enhances capabilities within life sciences applications [6] - The company aims to achieve adjusted EBITDA margins of 30% by 2027 [11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating the dynamic market environment and highlighted a robust backlog heading into 2026 [23] - The company anticipates a full year of 2025 with a book-to-bill ratio finishing at or slightly above one [23] - Management acknowledged the impact of tariffs on margins but remains optimistic about long-term growth opportunities in sectors like life sciences and clean energy [24][45] Other Important Information - The midpoint of adjusted EBITDA guidance for the full year was modified to $2.075 billion due to tariff impacts [15] - The adjusted tax rate is expected to be roughly 23.5%, with net interest expense around $220 million [16] Q&A Session Summary Question: Market perspective and momentum into 2026 - Management noted continued organic order growth and positive trends across regions, with a focus on controlling controllable factors [21][22] Question: Margin commentary and expectations for 2026 - Management expects margin expansion in 2026, though it may be muted in the first half due to ongoing tariff impacts [26] Question: Tariff headwinds and pricing dynamics - The gross headwind from tariffs is now slightly over $100 million, with pricing actions taken to offset these costs [39] Question: Clean energy market performance - Management indicated that clean energy remains a good end market, with expectations for improved performance in 2026 [45] Question: Competitive dynamics and pricing strategies - Management confirmed that pricing will remain sticky, and they are focused on maintaining price increases despite tariff fluctuations [60]